Dw. Bates et al., THE COSTS OF ADVERSE DRUG EVENTS IN HOSPITALIZED-PATIENTS, JAMA, the journal of the American Medical Association, 277(4), 1997, pp. 307-311
Objective.-To assess the additional resource utilization associated wi
th an adverse drug event (ADE). Design.-Nested case-control study with
in a prospective cohort study, Participants.-The cohort included 4108
admissions to a stratified random sample of 11 medical and surgical un
its in 2 tertiary-care hospitals over a 6-month period. Cases were pat
ients with an ADE, and the control for each case was the patient on th
e same unit as the case with the most similar pre-event length of stay
. Main Outcome Measures.-Postevent length of stay and total costs. Met
hods.-Incidents were detected by self-report stimulated by nurses and
pharmacists and by daily chart review, and were classified as to wheth
er they represented ADEs. Information on length of stay and charges wa
s obtained from billing data, and costs were estimated by multiplying
components of charges times hospital-specific ratios of costs to charg
es. Results.-During the study period, there were 247 ADEs among 207 ad
missions. After outliers and multiple episodes were excluded, there we
re 190 ADEs, of which 60 were preventable. In paired regression analys
es adjusting for multiple factors, including severity, comorbidity, an
d case mix, the additional length of stay associated with an ADE was 2
.2 days (P=.04), and the increase in cost associated with an ADE was $
3244 (P=.04). For preventable ADEs, the increases were 4.6 days in len
gth of stay (P=.03) and $5857 in total cost (P=.07). After adjusting f
or our sampling strategy, the estimated postevent costs attributable t
o an ADE were $2595 for all ADEs and $4685 for preventable ADEs. Based
on these costs and data about the incidence of ADEs, we estimate that
the annual costs attributable to all ADEs and preventable ADEs for a
700-bed teaching hospital are $5.6 million and $2.8 million, respectiv
ely. Conclusions.-The substantial costs of ADEs to hospitals justify i
nvestment in efforts to prevent these events. Moreover, these estimate
s are conservative because they do not include the costs of injuries t
o patients or malpractice costs.